The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used psychopharmaceutical treatment for major depressive disorder (MDD), but individual responses to SSRIs vary greatly. CYP2C19 is a key enzyme involved in the metabolism of several drugs, including SSRIs. Variations in the CYP2C...
Saved in:
Main Authors: | Win Lee Edwin Wong (Author), Chiara Fabbri (Author), Benjamin Laplace (Author), Danyang Li (Author), Roos van Westrhenen (Author), Cathryn M. Lewis (Author), Gavin Stewart Dawe (Author), Allan H. Young (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography
by: Agacayak KS, et al.
Published: (2019) -
Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
by: Eliasz Panek, et al.
Published: (2023) -
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024) -
Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011) -
Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013)